- 2.7Impact Factor
- 4.5CiteScore
- 23 daysTime to First Decision
Special Issues
Antibodies publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Coronavirus-Targeting Antibodies
Deadline: 1 August 2023
Antibodies: 10th Anniversary
Deadline: 30 April 2023
The Role of Antibodies in SARS-CoV-2 Infection
Deadline: 20 April 2023
Monoclonal Antibody-Directed Therapy Series II
Deadline: 20 December 2022
New, Old, and Shared Antibody Specificities in Autoimmune Diseases
Deadline: 20 September 2022
Women's Special Issue Series: Recent Development for Improved Therapeutic Antibodies
Deadline: 30 June 2022
Antibodies, B Cell Responses and Immune Responses to SARS-CoV-2 Infections
Deadline: 20 March 2022
CAR-T Cell Metabolism
Deadline: 28 February 2022
Reviews on Antibodies and Antigens
Deadline: 31 October 2021
Advances in Antibody–Drug Conjugates (ADCs)
Deadline: 10 October 2021
Antibody Engineering for Cancer Immunotherapy
Deadline: 31 August 2021
Design, Production and Characterization of Peptide Antibodies
Deadline: 20 May 2021
of 4

